Small vulnerable newborns-big potential for impact.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
20 05 2023
Historique:
received: 13 11 2022
revised: 27 01 2023
accepted: 14 02 2023
medline: 22 5 2023
pubmed: 12 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

Despite major achievements in child survival, the burden of neonatal mortality has remained high and even increased in some countries since 1990. Currently, most neonatal deaths are attributable to being born preterm, small for gestational age (SGA), or with low birthweight (LBW). Besides neonatal mortality, these conditions are associated with stillbirth and multiple morbidities, with short-term and long-term adverse consequences for the newborn, their families, and society, resulting in a major loss of human capital. Prevention of preterm birth, SGA, and LBW is thus critical for global child health and broader societal development. Progress has, however, been slow, largely because of the global community's failure to agree on the definition and magnitude of newborn vulnerability and best ways to address it, to frame the problem attractively, and to build a broad coalition of actors and a suitable governance structure to implement a change. We propose a new definition and a conceptual framework, bringing preterm birth, SGA, and LBW together under a broader umbrella term of the small vulnerable newborn (SVN). Adoption of the framework and the unified definition can facilitate improved problem definition and improved programming for SVN prevention. Interventions aiming at SVN prevention would result in a healthier start for live-born infants, while also reducing the number of stillbirths, improving maternal health, and contributing to a positive economic and social development in the society.

Identifiants

pubmed: 37167991
pii: S0140-6736(23)00354-9
doi: 10.1016/S0140-6736(23)00354-9
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1692-1706

Subventions

Organisme : Medical Research Council
ID : MR/S004971/1
Pays : United Kingdom

Investigateurs

Yemisrach Okwaraji (Y)
Julia Krasevec (J)
Ellen Bradley (E)
Joel Conkle (J)
Gretchen Stevens (G)
Giovanna Gatica (G)
Eric O Ohuma (EO)
Chris Coffey (C)
Diana Estevez Dominguez (D)
Hannah Blencowe (H)
Ben Kimathi (B)
Ann Beth Moller (AB)
Alexandra Lewin (A)
Laith Hussain-Alkhateeb (L)
Nita Dalmiya (N)
Joy E Lawn (JE)
Elaine Borghi (E)
Chika Hayashi (C)

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests PA reports a grant from Children's Investment Fund Foundation, during the conduct of the study. All other authors declare no competing interests.

Auteurs

Per Ashorn (P)

Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Paediatrics, Tampere University Hospital, Tampere, Finland. Electronic address: per.ashorn@tuni.fi.

Ulla Ashorn (U)

Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Yvonne Muthiani (Y)

Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Samira Aboubaker (S)

Geneva, Switzerland.

Sufia Askari (S)

Sight and Life, Kaiseraugst, Switzerland.

Rajiv Bahl (R)

Indian Council for Medical Research, New Delhi, India.

Robert E Black (RE)

Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Nita Dalmiya (N)

United Nations Children's Fund, New York, NY, USA.

Christopher P Duggan (CP)

Center for Nutrition, Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.

G Justus Hofmeyr (GJ)

Department of Obstetrics and Gynaecology, University of Botswana, Gaborone, Botswana; Effective Care Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Department of Obstetrics and Gynaecology, Walter Sisulu University, East London, South Africa.

Stephen H Kennedy (SH)

Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.

Nigel Klein (N)

UCL Great Ormond Street Institute of Child Health, University College London, London, UK.

Joy E Lawn (JE)

Maternal, Adolescent, Reproductive & Child Health Centre, London School of Hygiene & Tropical Medicine, London, UK.

Jeremy Shiffman (J)

Paul H Nitze School of Advanced International Studies, Johns Hopkins University, Baltimore, MD, USA.

Jonathon Simon (J)

Condon, MT, USA.

Marleen Temmerman (M)

Centre of Excellence in Women and Child Health, Aga Khan University, Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH